Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Optics Express|November 22, 2024
Ground-based simulation of laser link acquisition for inter-satellite laser interferometryQi-Lin Hu, Jing-Yi Zhang, Rui-Liang Nie, et al.
Journal for Immunotherapy of Cancer|August 15, 2020
Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancerZhihao Lu, Huan Chen, Shuang Li, et al.
NPJ Precision Oncology|May 5, 2021
A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancerXi Jiao, Xin Wei, Shuang Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled TrialZhihao Lu, Yu Fang, Chang Liu, et al.
Frontiers in Immunology|September 26, 2022
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancersYanni Wang, Jianling Zou, Yun Li, et al.
Cancer Biology & Medicine|September 27, 2021
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancerYujiao Wang, Xi Jiao, Shuang Li, et al.
NPJ Vaccines|June 18, 2026
Development of a multi-epitope mRNA vaccine targeting tumor-associated antigens for esophageal squamous cell carcinomaHenghui Zhang, Hao Liang, Tingting Dai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2025
NOTCH1 Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 TrialZhihao Lu, Wenting Du, Xi Jiao, et al.
Journal for Immunotherapy of Cancer|August 15, 2020
Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifierZhihao Lu, Huan Chen, Xi Jiao, et al.
Signal Transduction and Targeted Therapy|June 27, 2024
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinomaYanni Wang, Chang Liu, Huan Chen, et al.
Pageof 8